Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model

Overview

Journal Drugs R D

Specialty Pharmacology

Date 2021 Jun 15

PMID 34128200

Authors

Masaharu Hirano

Tatsuaki Okamura

Tetsuji Nagano

Shigeyuki Nonaka

Tsutomu Shiroya

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Anaphylactic shock is a serious adverse drug reaction that can occur in response to contrast media used during coronary computed tomography angiography. The imaging quality of coronary computed tomography angiography is improved by β-blockers, which decrease heart rate. In this study, we sought to analyze anaphylactic shock treatment in patients receiving short-acting β1-blockers.

Methods: We examined the influence of epinephrine and glucagon on hemodynamics during β-blocker treatment, using a dog histamine shock model; the β1-blocker landiolol hydrochloride was used. The effects of these drugs were assessed by recording changes relative to established baselines.

Results: Histamine and landiolol decreased mean blood pressure. Histamine exerted no apparent effect on heart rate, whereas landiolol decreased heart rate. Further, landiolol reduced histamine-mediated increases in the force of cardiac contraction. Increasing the doses of epinephrine and glucagon ameliorated anaphylactic shock-induced deterioration in hemodynamic parameters in subjects receiving landiolol.

Conclusions: In patients receiving landiolol for coronary computed tomography angiography, deterioration in hemodynamic parameters due to anaphylactic shock can be mitigated by increasing the doses of epinephrine and glucagon. Clinicians should thus prepare appropriate amounts of epinephrine and glucagon prior to coronary computed tomography angiography.

References

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

Lang D, Alpern M, Visintainer P, Smith S . Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med. 1991; 115(4):270-6. DOI: 10.7326/0003-4819-115-4-270. View

Miller J, Rochitte C, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I . Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008; 359(22):2324-36. DOI: 10.1056/NEJMoa0806576. View

Lasser E, Walters A, REUTER S, LANG J . Histamine release by contrast media. Radiology. 1971; 100(3):683-6. DOI: 10.1148/100.3.683. View

Antman E, Anbe D, Armstrong P, Bates E, Green L, Hand M . ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the.... Circulation. 2004; 110(9):e82-292. View

Hamm C, Bassand J, Agewall S, Bax J, Boersma E, Bueno H . ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment.... Eur Heart J. 2011; 32(23):2999-3054. DOI: 10.1093/eurheartj/ehr236. View

Hirano M, Yamashina A, Hara K, Ikari Y, Jinzaki M, Iino M . A multicenter, open-label study of an intravenous short-acting β1-adrenergic receptor antagonist landiolol hydrochloride for coronary computed tomography angiography by 16-slice multi-detector computed tomography in Japanese patients with suspected.... Drugs R D. 2014; 14(3):185-94. PMC: 4153968. DOI: 10.1007/s40268-014-0056-6. View

Pinet A, Corot C, BIOT N, Eloy R . Evaluation of histamine release following intravenous injection of ionic and nonionic contrast media. Invest Radiol. 1988; 23 Suppl 1:S174-7. DOI: 10.1097/00004424-198809001-00030. View

Jinzaki M, Hirano M, Hara K, Suzuki T, Yamashina A, Ikari Y . A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease. Int J Cardiovasc Imaging. 2013; 29 Suppl 1:7-20. PMC: 3722440. DOI: 10.1007/s10554-013-0253-3. View

10.

Mark D, Berman D, Budoff M, Carr J, Gerber T, Hecht H . ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation. 2010; 121(22):2509-43. DOI: 10.1161/CIR.0b013e3181d4b618. View

11.

Simons F, Ardusso L, Bilo M, El-Gamal Y, Ledford D, Ring J . World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2012; 4(2):13-37. PMC: 3500036. DOI: 10.1097/WOX.0b013e318211496c. View

12.

Bluemke D, Achenbach S, Budoff M, Gerber T, Gersh B, Hillis L . Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on.... Circulation. 2008; 118(5):586-606. DOI: 10.1161/CIRCULATIONAHA.108.189695. View

13.

Hirano M, Yamashina A, Hara K, Ikari Y, Jinzaki M, Iino M . A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease. Clin Drug Investig. 2013; 34(1):53-62. PMC: 3889825. DOI: 10.1007/s40261-013-0149-y. View

14.

Hirano M, Hara K, Ikari Y, Jinzaki M, Iino M, Hamada C . Dose-finding study of landiolol hydrochloride: a short-acting β1-blocker for controlling heart rate during coronary computed-tomography angiography in Japan. Adv Ther. 2013; 30(9):803-18. PMC: 3824371. DOI: 10.1007/s12325-013-0053-0. View

15.

Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K . Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990; 175(3):621-8. DOI: 10.1148/radiology.175.3.2343107. View

16.

Amsterdam E, Wenger N, Brindis R, Casey Jr D, Ganiats T, Holmes Jr D . 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130(25):e344-426. DOI: 10.1161/CIR.0000000000000134. View

17.

Mollet N, Cademartiri F, van Mieghem C, Runza G, McFadden E, Baks T . High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005; 112(15):2318-23. DOI: 10.1161/CIRCULATIONAHA.105.533471. View